MA39860A - Formes polymorphes de la furazidine - Google Patents

Formes polymorphes de la furazidine

Info

Publication number
MA39860A
MA39860A MA039860A MA39860A MA39860A MA 39860 A MA39860 A MA 39860A MA 039860 A MA039860 A MA 039860A MA 39860 A MA39860 A MA 39860A MA 39860 A MA39860 A MA 39860A
Authority
MA
Morocco
Prior art keywords
furazidin
polymorphic forms
nitrofuran
imidazolidin
ylidene
Prior art date
Application number
MA039860A
Other languages
English (en)
Inventor
Vilnis Liepins
Nina Lukjanova
Evgenij Matiushenkov
Jekaterina Revjuka
Mikhail Skomorokhov
Original Assignee
Akciju Sabiedriba Olainfarm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akciju Sabiedriba Olainfarm filed Critical Akciju Sabiedriba Olainfarm
Publication of MA39860A publication Critical patent/MA39860A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

L'invention concerne les formes cristallines de la furazidine (1-{[(1e,2e)-3-(5-nitrofuran-2-yl)prop-2-ène-1-ylidène]amino}imidazolidine-2,4-dione) et des procédés de préparation de celles-ci.
MA039860A 2014-05-29 2015-05-27 Formes polymorphes de la furazidine MA39860A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LVP-14-44A LV15081B (lv) 2014-05-29 2014-05-29 Furazidīna polimorfās formas

Publications (1)

Publication Number Publication Date
MA39860A true MA39860A (fr) 2015-12-03

Family

ID=53969380

Family Applications (1)

Application Number Title Priority Date Filing Date
MA039860A MA39860A (fr) 2014-05-29 2015-05-27 Formes polymorphes de la furazidine

Country Status (6)

Country Link
EP (1) EP3148988A1 (fr)
EA (1) EA201692217A1 (fr)
LV (1) LV15081B (fr)
MA (1) MA39860A (fr)
UA (1) UA115290C2 (fr)
WO (1) WO2015181741A1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2990402A (en) 1958-10-07 1961-06-27 Smith Kline French Lab Preparation of 1-aminohydantoin derivatives
FR1489091A (fr) 1966-05-09 1967-07-21 Clin Byla Ets Nouvelles hydantoïnes et leur préparation
WO1997019930A1 (fr) 1995-11-27 1997-06-05 Lonza Ag Procede de production de 1-aminohydantoine
PL185120B1 (pl) 1997-03-17 2003-02-28 Adamed Sp Z Oo Sposób┴wytwarzania┴1-{[3-(5-nitro-2-furylo)-2-propenylideno]-amino}-2,4-imidazolidynodionu

Also Published As

Publication number Publication date
LV15081A (lv) 2015-12-20
EP3148988A1 (fr) 2017-04-05
WO2015181741A1 (fr) 2015-12-03
UA115290C2 (uk) 2017-10-10
LV15081B (lv) 2016-11-20
EA201692217A1 (ru) 2017-05-31

Similar Documents

Publication Publication Date Title
EP3600318A4 (fr) Procédés d'utilisation d'inhibiteurs d'ehmt2
IL268625A (en) Amino pyrimidine compounds used as SSAO inhibitors
EP3703743A4 (fr) Procédés d'immunothérapie orale
HUE057926T2 (hu) Eljárás tiokarbonátok elõállítására
PT3534743T (pt) Calçado, e método de preparar o mesmo
EP3399996A4 (fr) Procédés d'administration d'hepcidine
IL273896A (en) Crystal forms of 3-disubstituted 1, 2, 4-oxadiazole
EP3565542A4 (fr) Formes polymorphes de rad1901-2hcl
EP3337485A4 (fr) Formes cristallines d'ibrutinib
EP3185655B8 (fr) Procédé de codage individuel de substrats métal-céramiques
ZA201808014B (en) Adenine derivatives as protein kinase inhibitors
WO2014174456A3 (fr) Formes polymorphiques de chlorhydrate de nilotinib
EP3250562A4 (fr) Formes cristallines de c21h22ci2n4o2
EP3530650A4 (fr) Forme cristalline de (r)-4-hydroxy-2-oxo-1-pyrrolidineacétamide, son procédé de préparation et son utilisation
EP3323811A4 (fr) Procédé de production d'un composé hétérocyclique contenant de l'azote et intermédiaire dudit composé hétérocyclique contenant de l'azote
EP3310358A4 (fr) Compositions et procédés pour le traitement de troubles d'utilisation de substances, d'accoutumance, et de troubles psychiatriques
IL293192A (en) Methods for the preparation of indolinobenzodiazepine derivatives
EP3465203A4 (fr) Procédés d'immunothérapie
EP3247399A4 (fr) Formes cristallines d'éfinaconazole
IL269792B (en) Crystalline forms of (s)–apoxolner
EP3216791A4 (fr) Substance polymorphe de chlorhydrate de yonkenafil, son procédé de préparation, composition à base de ladite substance et utilisation deladite substance
EP3181556A4 (fr) Composé micromoléculaire, son procédé de synthèse et application associée
EP3702356A4 (fr) Composé époxy-oxétane, procédé de synthèse de celui-ci, et utilisation dudit composé
MX2019010640A (es) Formas cristalinas de acido obeticolico.
EP3277665A4 (fr) Analogues d'indole en tant qu'antagonistes des récepteurs 5-oxo-ete et procédé d'utilisation de ceux-ci